1. Targeted deletion of GD3 synthase protects against MPTP‐induced neurodegeneration
   Y. Akkhawattanangkul et al, 2017, Genes, Brain and Behavior CrossRef
2. Pretreatment of glial cell‐derived neurotrophic factor and geranylgeranylacetone ameliorates brain injury in Parkinson's disease by its anti‐apoptotic and anti‐oxidative property
   Peijian Yue et al, 2018, Journal of Cellular Biochemistry CrossRef
3. The Brain-Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression
   Maryam Rahmani et al, 2020, Neurochemical Research CrossRef
4. A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson’s Disease
   Oleg V. Ardashov et al, 2019, ACS Chemical Neuroscience CrossRef
5. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson’s disease
   Bin Liu et al, 2017, Neurological Research CrossRef
6. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson’s Disease
   Wook Jin, 2020, Journal of Clinical Medicine CrossRef
7. The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update
   Rhun Yian Koh et al, 2023, CNS & Neurological Disorders - Drug Targets CrossRef
8. Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease
   Éva Szökő et al, 2018, Journal of Neural Transmission CrossRef
9. Jia-Jian-Di-Huang-Yin-Zi decoction exerts neuroprotective effects on dopaminergic neurons and their microenvironment
   Jingsi Zhang et al, 2018, Scientific Reports CrossRef
10. Neurodegeneration in diabetic retinopathy: Potential for novel therapies
    Alistair J. Barber et al, 2017, Vision Research CrossRef
11. In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson’s Disease
    Jin Choi et al, 2016, International Journal of Molecular Sciences CrossRef
12. Monoamine oxidase-B inhibitor protects degenerating spinal neurons, enhances nerve regeneration and functional recovery in sciatic nerve crush injury model
    Al-Shimali M. Hussain et al, 2018, Neuropharmacology CrossRef
13. Echinacoside Protects Against MPP+-Induced Neuronal Apoptosis via ROS/ATF3/CHOP Pathway Regulation
    Qing Zhao et al, 2016, Neuroscience Bulletin CrossRef
14. Comparison of the proteome patterns of adipose-derived stem cells with those treated with selegiline using a two dimensional gel electrophoresis analysis
    M. Mardani et al, 2020, Biotechnic & Histochemistry CrossRef
15. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
    Naif H. Ali et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
16. Neuroprotective effects of selegiline on rat neural stem cells treated with hydrogen peroxide
    Alireza Abdanipour et al, 2017, Biomedical Reports CrossRef
17. Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis
    Farzaneh Rahmani et al, 2019, Brain Research CrossRef
18. Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson׳s disease
    Bin Liu et al, 2015, Brain Research CrossRef
19. Effect of selegiline as a monomine oxidase B inhibitor on the expression of neurotrophin mRNA levels in a contusion rat model of spinal cord injury
    Alireza Abdanipour et al, 2023, Neurological Research CrossRef
20. Chronic treatment with enhancer drugs modifies the gene expression of selected parameters related to brain plasticity in rats under stress conditions
    K. Hrivikova et al, 2022, Neurochemistry International CrossRef
21. Type-B monoamine oxidase inhibitors in neurological diseases
    Marika Alborghetti et al, 2024, Neural Regeneration Research CrossRef
22. Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson’s disease: a meta-analysis
    De-Qi Jiang et al, 2020, Aging Clinical and Experimental Research CrossRef
23. Synergistic Effect of Lovastatin and Selegiline on the Differentiation of Bone Marrow Stromal Cells Into Neuron-Like Cells
    Alireza Abdanipour et al, 2023, Jentashapir Journal of Cellular and Molecular Biology CrossRef
24. MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions
    Mauricio P. Cunha et al, 2017, Molecular Neurobiology CrossRef
25. Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson’s disease symptoms
    Akanksha Mishra et al, 2018, Biochemical Pharmacology CrossRef
26. Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson’s disease dementia
    Ming-Hong Hsieh et al, 2017, Brain Research Bulletin CrossRef
27. Neuroprotective Effects and Related Mechanisms of Echinacoside in MPTP-Induced PD Mice
    Zhen-Nian Zhang et al, 2021, Neuropsychiatric Disease and Treatment CrossRef
28. Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
    Edith Miville-Godbout et al, 2016, PLOS ONE CrossRef